Esophageal adenocarcinoma and obesity: Peritumoral adipose tissue plays a role in lymph node invasion

Oncotarget

Volumn 6, Issue 13, 2015, Pages 11203-11215

  Trevellin, Elisabetta ^a   Scarpa, Marco ^b   Carraro, Amedeo ^c   Lunardi, Francesca ^a   Kotsafti, Andromachi ^b   Porzionato, Andrea ^a   Saadeh, Luca ^b   Cagol, Matteo ^b   Alfieri, Rita ^b   Tedeschi, Umberto ^c   Calabrese, Fiorella ^a   Castoro, Carlo ^b   Vettor, Roberto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Adipose tissue; Esophageal adenocarcinoma; Metastasis obesity; Peritumoral microenvironment

Indexed keywords

ADIPONECTIN RECEPTOR; ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; LEPTIN; MESSENGER RNA; PODOPLANIN; UVOMORULIN; ACTA2 PROTEIN, HUMAN; ACTIN; CADHERIN; CDH1 PROTEIN, HUMAN; CONDITIONED MEDIUM; MEMBRANE PROTEIN; PDPN PROTEIN, HUMAN;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CANCER GROWTH; CELL SIZE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; OBESITY; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATOR GENE; TUMOR INVASION; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; ADENOCARCINOMA; COMPLICATION; CONDITIONED MEDIUM; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION; GENETICS; LYMPHANGIOGENESIS; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SECONDARY; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUE; TUMOR CELL CULTURE;

ACTINS; ADENOCARCINOMA; ADIPOCYTES; ADIPOSE TISSUE; AGED; ANTIGENS, CD31; CADHERINS; CELL SIZE; CULTURE MEDIA, CONDITIONED; EPITHELIAL-MESENCHYMAL TRANSITION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEPTIN; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OBESITY; PARACRINE COMMUNICATION; RECEPTORS, ADIPONECTIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUES; TUMOR CELLS, CULTURED;

EID: 84929629991     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3587     Document Type: Article

References (48)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, and Thun MJ. Cancer statistics, 2003. CA Cancer J Clin, 2003. 53(1): p. 5-26.
2. Refaely Y and Krasna MJ. Multimodality therapy for esophageal cancer. Surg Clin North Am, 2002. 82(4): p. 729-46.
3. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, and Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA, 2004. 291(23): p. 2847-50.
4. Wolk A, Gridley G, Svensson M, Nyren O, McLaughlin JK, Fraumeni JF, and Adam HO. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control, 2001. 12(1): p. 13-21.
5. Calle EE, Rodriguez C, Walker-Thurmond K, and Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med, 2003. 348(17): p. 1625-38.
6. Renehan AG, Tyson M, Egger M, Heller RF, and Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet, 2008. 371(9612): p. 569-78.
7. Hoffstedt J, Arner E, Wahrenberg H, Andersson DP, Qvisth V, Lofgren P, Ryden M, Thorne A, Wiren M, Palmer M, Thorell A, Toft E, and Arner P. Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity. Diabetologia, 2010. 53(12): p. 2496-503.
8. Liu A, McLaughlin T, Liu T, Sherman A, Yee G, Abbasi F, Lamendola C, Morton J, Cushman SW, Reaven GM, and Tsao PS. Differential intra-abdominal adipose tissue profiling in obese, insulin-resistant women. Obes Surg, 2009. 19(11): p. 1564-73.
9. Kim SH and Reaven G. Obesity and insulin resistance: an ongoing saga. Diabetes, 2010. 59(9): p. 2105-6.
10. Prieto-Hontoria PL, Perez-Matute P, Fernandez-Galilea M, Bustos M, Martinez JA, and Moreno-Aliaga MJ. Role of obesity-associated dysfunctional adipose tissue in cancer: a molecular nutrition approach. Biochim Biophys Acta, 2011. 1807(6): p. 664-78.
11. McTiernan A. Obesity and cancer: the risks, science, and potential management strategies. Oncology (Williston Park), 2005. 19(7): p. 871-81; discussion 881-2, 885-6.
12. Dalamaga M, Diakopoulos KN, and Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev, 2012. 33(4): p. 547-94.
13. Toren P, Mora BC, and Venkateswaran V. Diet, obesity, and cancer progression: are adipocytes the link? Lipid Insights, 2013. 6: p. 37-45.
14. Lundgren M, Svensson M, Lindmark S, Renstrom F, Ruge T, and Eriksson JW. Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'. Diabetologia, 2007. 50(3): p. 625-33.
15. Li FY, Cheng KK, Lam KS, Vanhoutte PM, and Xu A. Cross-talk between adipose tissue and vasculature: role of adiponectin. Acta Physiol (Oxf), 2011. 203(1): p. 167-80.
16. Ouchi N and Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta, 2007. 380(1-2): p. 24-30.
17. Goldstein BJ and Scalia R. Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab, 2004. 89(6): p. 2563-8.
18. Tsukada T, Fushida S, Harada S, Terai S, Yagi Y, Kinoshita J, Oyama K, Tajima H, Fujita H, Ninomiya I, Fujimura T, and Ohta T. Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer. J Exp Clin Cancer Res, 2011. 30: p. 107.
19. Hiyoshi M, Tsuno NH, Otani K, Kawai K, Nishikawa T, Shuno Y, Sasaki K, Hongo K, Kaneko M, Sunami E, Takahashi K, Nagawa H, and Kitayama J. Adiponectin receptor 2 is negatively associated with lymph node metastasis of colorectal cancer. Oncol Lett, 2012. 3(4): p. 756-760.
20. Byeon JS, Jeong JY, Kim MJ, Lee SM, Nam WH, Myung SJ, Kim JG, Yang SK, Kim JH, and Suh DJ. Adiponectin and adiponectin receptor in relation to colorectal cancer progression. Int J Cancer, 2010. 127(12): p. 2758-67.
21. Jeong YJ, Bong JG, Park SH, Choi JH, and Oh HK. Expression of leptin, leptin receptor, adiponectin, and adiponectin receptor in ductal carcinoma in situ and invasive breast cancer. J Breast Cancer, 2011. 14(2): p. 96-103.
22. Doyle SL, Donohoe CL, Finn SP, Howard JM, Lithander FE, Reynolds JV, Pidgeon GP, and Lysaght J. IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity. Am J Gastroenterol, 2012. 107(2): p. 196-204.
23. Hoda MR, Keely SJ, Bertelsen LS, Junger WG, Dharmasena D, and Barrett KE. Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. Br J Surg, 2007. 94(3): p. 346-54.
24. Vona-Davis L and Rose DP. Angiogenesis, adipokines and breast cancer. Cytokine Growth Factor Rev, 2009. 20(3): p. 193-201.
25. Jung JI, Cho HJ, Jung YJ, Kwon SH, Her S, Choi SS, Shin SH, Lee KW, and Park JH. High-fat diet-induced obesity increases lymphangiogenesis and lymph node metastasis in the B16F10 melanoma allograft model: Roles of adipocytes and M2-macrophages. Int J Cancer, 2015;136(2):258-70
26. Clasper S, Royston D, Baban D, Cao Y, Ewers S, Butz S, Vestweber D, and Jackson DG. A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis. Cancer Res, 2008. 68(18): p. 7293-303.
27. Silha JV, Krsek M, Sucharda P, and Murphy LJ. Angiogenic factors are elevated in overweight and obese individuals. Int J Obes (Lond), 2005. 29(11): p. 1308-14.
28. Hausman GJ and Richardson RL. Adipose tissue angiogenesis. J Anim Sci, 2004. 82(3): p. 925-34.
29. Guo S, Liu M, Wang G, Torroella-Kouri M, and Gonzalez-Perez RR. Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells. Biochim Biophys Acta, 2012. 1825(2): p. 207-22.
30. Yan D, Avtanski D, Saxena NK, and Sharma D. Leptininduced epithelial-mesenchymal transition in breast cancer cells requires beta-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways. J Biol Chem, 2012. 287(11): p. 8598-612.
31. Feng H, Liu Q, Zhang N, Zheng L, Sang M, Feng J, Zhang J, Wu X, and Shan B. Leptin promotes metastasis by inducing an epithelial-mesenchymal transition in A549 lung cancer cells. Oncol Res, 2014. 21(3): p. 165-71.
32. Zhao L, Shen ZX, Luo HS, and Shen L. Possible involvement of leptin and leptin receptor in developing gastric adenocarcinoma. World J Gastroenterol, 2005. 11(48): p. 7666-70.
33. Koda M, Sulkowska M, Kanczuga-Koda L, Surmacz E, and Sulkowski S. Overexpression of the obesity hormone leptin in human colorectal cancer. J Clin Pathol, 2007. 60(8): p. 902-6.
34. Howard JM, Beddy P, Ennis D, Keogan M, Pidgeon GP, and Reynolds JV. Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma. Br J Surg, 2010. 97(7): p. 1020-7.
35. Shah NR and Braverman ER. Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin. PLoS One, 2012. 7(4): p. e33308.
36. Ando S and Catalano S. The multifactorial role of leptin in driving the breast cancer microenvironment. Nat Rev Endocrinol, 2012. 8(5): p. 263-75.
37. Howard JM, Pidgeon GP, and Reynolds JV. Leptin and gastro-intestinal malignancies. Obes Rev, 2010. 11(12): p. 863-74.
38. Riondino S, Roselli M, Palmirotta R, Della-Morte D, Ferroni P, and Guadagni F. Obesity and colorectal cancer:role of adipokines in tumor initiation and progression. World J Gastroenterol, 2014. 20(18): p. 5177-90.
39. Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, Nonas C, and Kahn R. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Am J Clin Nutr, 2007. 85(5): p. 1197-202.
40. Neeland IJ, Ayers CR, Rohatgi AK, Turer AT, Berry JD, Das SR, Vega GL, Khera A, McGuire DK, Grundy SM, and de Lemos JA. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity (Silver Spring), 2013. 21(9): p. E439-47.
41. Bain GH, Collie-Duguid E, Murray GI, Gilbert FJ, Denison A, McKiddie F, Ahearn T, Fleming I, Leeds J, Phull P, Park K, Nanthakumaran S, Grabsch HI, Tan P, Welch A, Schweiger L, Dahle-Smith A, Urquhart G, Finegan M, and Petty RD. Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas. Br J Cancer, 2014. 110(6): p. 1525-34.
42. Park J, Euhus DM, and Scherer PE. Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr Rev, 2011. 32(4): p. 550-70.
43. Scarpace PJ, Matheny M, Strehler KY, Toklu HZ, Kirichenko N, Carter CS, Morgan D, and Tumer N. Rapamycin Normalizes Serum Leptin by Alleviating Obesity and Reducing Leptin Synthesis in Aged Rats. J Gerontol A Biol Sci Med Sci, 2015. Epub ahead of print.
44. Leontieva OV, Paszkiewicz GM, and Blagosklonny MV. Comparison of rapamycin schedules in mice on high-fat diet. Cell Cycle, 2014. 13(21): p. 3350-6.
45. Blagosklonny MV. Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions. Oncotarget, 2012. 3(12): p. 1711-24.
46. Edge SB and Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 2010. 17(6): p. 1471-4.
47. Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, Zaninotto G, Bonavina L, and Peracchia A. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer, 2001. 91(11):p. 2165-74.
48. Ruol A, Castoro C, Portale G, Cavallin F, Sileni VC, Cagol M, Alfieri R, Corti L, Boso C, Zaninotto G, Peracchia A, and Ancona E. Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution. Arch Surg, 2009. 144(3): p. 247-54; discussion 254.